---
title: MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis
nct_id: NCT04114708
overall_status: WITHDRAWN
phase: NA
sponsor: NYU Langone Health
study_type: INTERVENTIONAL
primary_condition: Ruptured Achilles Tendon
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04114708.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04114708"
ct_last_update_post_date: 2022-07-08
last_seen_at: "2026-05-12T06:01:09.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis

**NCT ID:** [NCT04114708](https://clinicaltrials.gov/study/NCT04114708)

## Key Facts

- **Status:** WITHDRAWN
- **Why Stopped:** Lack of funding
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 0
- **Lead Sponsor:** NYU Langone Health
- **Conditions:** Ruptured Achilles Tendon
- **Start Date:** 2022-01
- **Completion Date:** 2022-10
- **CT.gov Last Update:** 2022-07-08

## Brief Summary

The purpose of the proposed study is to evaluate the effect of lateral extra-articular tenodesis (LET) on anterior cruciate ligament reconstruction through evaluation of postoperative magnetic resonance imaging (MRI). This will be a single-center non-randomized controlled study. The study is comparing postoperative graft MRI findings in two cohorts: patients undergoing isolated ACLR and patients undergoing ACLR with lateral extra-articular tenodesis (LET). Postoperative MRIs will be obtained at 6, 9 and 12 months postoperatively.

## Eligibility

- **Minimum age:** 13 Years
- **Maximum age:** 25 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* ACL deficient knee
* skeletally mature (as defined by closed growth plates on plain radiograph)
* at least 13 years of age
* less than 26 years of age
* not pregnant
* two or more of following criteria: competitive pivoting sport, grade 2 pivot shift or - greater, generalized ligament laxity (beighton score of 4 or greater )
* no concomitant lateral meniscus tear

Exclusion Criteria:

* knee with intact ACL
* skeletally immature (as defined by open physis on plain radiograph)
* less than two of following criteria: competitive pivoting sport, grade 2 pivot shift or - greater, generalized ligament laxity (beighton score of 4 or greater )
* pregnant
* less than 13 years of age
* older than age 25
* previous ACL repair
* concomitant lateral meniscus tear
* unable to speak english or perform informed consent
* multiligamentous knee injury (two or more ligaments requiring surgical attention)
* varus or valgus malalignment greater than 3 degrees
```

## Arms

- **ACLR** (OTHER) — All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.
- **ACLR with lateral extra-articular tenodesis** (OTHER) — All LETs will be performed in a standardized fashion using the modified Lameire technique.

## Interventions

- **Anterior cruciate ligament Reconstruction (ACLR)** (DIAGNOSTIC_TEST) — All patients will undergo an anatomic ACLR via a standardized fashion using BTB autograft.
- **ACLR with lateral extra-articular tenodesis (LET)** (DIAGNOSTIC_TEST) — All LETs will be performed in a standardized fashion using the modified Lameire technique. All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.

## Primary Outcomes

- **Determine if ACLR supplementation with LET results in superior MRI findings relative to ACLR alone** _(time frame: 1 Year)_ — MRI findings will be compared in patients receiving ACLR+LET versus just ACLR

## Secondary Outcomes

- **Graft Failure** _(time frame: 1 Year)_

## Locations (1)

- NYU Langone Health, New York, New York, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.nyu langone health|new york|new york|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04114708.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04114708*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*